GB2146351A - Monoclonal antibody - Google Patents
Monoclonal antibodyInfo
- Publication number
- GB2146351A GB2146351A GB08423719A GB8423719A GB2146351A GB 2146351 A GB2146351 A GB 2146351A GB 08423719 A GB08423719 A GB 08423719A GB 8423719 A GB8423719 A GB 8423719A GB 2146351 A GB2146351 A GB 2146351A
- Authority
- GB
- United Kingdom
- Prior art keywords
- monoclonal antibody
- alpha
- sub
- type human
- human interferon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A monoclonal antibody having a greater binding efficiency to D sub-type human interferon- alpha than to A sub-type human interferon- alpha . A particular monoclonal antibody is designated YOK5/19. A process is described for the preparation of the monoclonal antibody and uses of the monoclonal antibody in immunopurification and immunoassay are described.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838303165A GB8303165D0 (en) | 1983-02-04 | 1983-02-04 | Monoclonal antibody |
| PCT/GB1984/000031 WO1984003105A1 (en) | 1983-02-04 | 1984-02-06 | Monoclonal antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8423719D0 GB8423719D0 (en) | 1984-10-24 |
| GB2146351A true GB2146351A (en) | 1985-04-17 |
| GB2146351B GB2146351B (en) | 1986-10-22 |
Family
ID=10537497
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB838303165A Pending GB8303165D0 (en) | 1983-02-04 | 1983-02-04 | Monoclonal antibody |
| GB08423719A Expired GB2146351B (en) | 1983-02-04 | 1984-02-06 | Monoclonal antibody |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB838303165A Pending GB8303165D0 (en) | 1983-02-04 | 1983-02-04 | Monoclonal antibody |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0134803A1 (en) |
| JP (1) | JPS60500714A (en) |
| GB (2) | GB8303165D0 (en) |
| WO (1) | WO1984003105A1 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3306060A1 (en) * | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | NEW IMMUNGLOBULIN-PRODUCING HYBRID CELL LINES, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF |
| FR2560212B1 (en) * | 1984-02-24 | 1989-12-29 | Unicet | MONOCLONAL ANTIBODIES AGAINST INTERFERON A2 AND HYBRIDOMAS PRODUCING SUCH ANTIBODIES |
| PT741577E (en) * | 1994-03-07 | 2003-03-31 | Imperial College | USING THE ALPHA INTERFERENCE SUBTYPE 8 IN THE PREPARATION OF MEDICINES FOR TREATING FIGURE VIRAL INFECTIONS |
| US7087726B2 (en) | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
| EP2712930A3 (en) | 2006-12-06 | 2014-04-23 | MedImmune, LLC | Interferon alpha-induced pharmacodynamic markers |
| CA2686861A1 (en) | 2007-05-03 | 2008-11-13 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| NZ585064A (en) | 2007-11-05 | 2012-08-31 | Medimmune Llc | Methods of treating scleroderma |
| KR20110005783A (en) | 2008-02-08 | 2011-01-19 | 메디뮨 엘엘씨 | Disease Markers and Their Uses |
| CA2772921A1 (en) | 2009-09-03 | 2011-03-10 | Medimmune, Llc | Type 1 interferon diagnostic |
| SG11202108679PA (en) | 2019-02-15 | 2021-09-29 | Astrazeneca Ab | Type i interferon-mediated disorders |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1981002899A1 (en) * | 1980-04-11 | 1981-10-15 | D Secher | Monoclonal antibody |
| WO1982001773A1 (en) * | 1980-11-07 | 1982-05-27 | Secher David S | Assay for interferon |
| FR2500754A1 (en) * | 1981-02-27 | 1982-09-03 | Hoffmann La Roche | MONOCLONAL ANTIBODIES |
-
1983
- 1983-02-04 GB GB838303165A patent/GB8303165D0/en active Pending
-
1984
- 1984-02-06 WO PCT/GB1984/000031 patent/WO1984003105A1/en not_active Ceased
- 1984-02-06 GB GB08423719A patent/GB2146351B/en not_active Expired
- 1984-02-06 EP EP19840900633 patent/EP0134803A1/en not_active Ceased
- 1984-02-06 JP JP59500767A patent/JPS60500714A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1981002899A1 (en) * | 1980-04-11 | 1981-10-15 | D Secher | Monoclonal antibody |
| WO1982001773A1 (en) * | 1980-11-07 | 1982-05-27 | Secher David S | Assay for interferon |
| FR2500754A1 (en) * | 1981-02-27 | 1982-09-03 | Hoffmann La Roche | MONOCLONAL ANTIBODIES |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1984003105A1 (en) | 1984-08-16 |
| JPS60500714A (en) | 1985-05-16 |
| GB8423719D0 (en) | 1984-10-24 |
| EP0134803A1 (en) | 1985-03-27 |
| GB8303165D0 (en) | 1983-03-09 |
| GB2146351B (en) | 1986-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL76459A (en) | Method and kit for competitive immunoassay of antigens | |
| IL69861A (en) | Immunoassay of antigens and kit therefor | |
| GB2196634B (en) | Monoclonal antibodies to hiv and related peptides | |
| AU1085488A (en) | Monoclonal antibodies to a pan-malarial antigen | |
| IL76142A0 (en) | Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof | |
| DE3377531D1 (en) | Immunoassay of antigens | |
| GB2128630A (en) | Method of affinity purification employing monoclonal antibodies | |
| IL88375A0 (en) | Monoclonal antibodies to interferon-beta 2 and method of purification of interferon-beta 2 | |
| EP0415920A4 (en) | Monoclonal antibody specific to hiv antigens | |
| ZA846433B (en) | Antigens and monoclonal antibodies reactive against sprozoites of eimeria spp | |
| HUT38391A (en) | Process for preparing new monoclonal antibodies against glycoconjugates and for the utilization thereof | |
| GB2146351A (en) | Monoclonal antibody | |
| GB8304538D0 (en) | Antibodies and antigens | |
| ZA846436B (en) | Antigens and monoclonal antibodies reactive against merozites of eimeria spp | |
| AU6373286A (en) | Auto-anti-idiotypic monoclonal antibodies to steroid receptals and uses thereof | |
| AU550364B2 (en) | Immunogen of lidocaine-protein conjugate and antibodies derived therefrom | |
| NZ234049A (en) | Peptide epitopes of, and antibodies to htlv-1 | |
| DE3479671D1 (en) | Improvements in or relating to antibody preparations | |
| EP0269526A3 (en) | Method of quantitative determination of antigens and antibodies | |
| EP0159025A3 (en) | Monoclonal antibody specific to human alpha2-plasmin | |
| EP0119528A3 (en) | Monoclonal antibodies to human renal cancer antigens and method | |
| IL94389A0 (en) | Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and method of using same for diagnosis and treatment | |
| GB8418916D0 (en) | Antibodies and antibody-containing compositions | |
| GB2207921B (en) | Monoclonal antibody to omega-gliadin and hybridoma thereof | |
| EP0407586A4 (en) | Human monoclonal antibody and process for its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |